A Closer Look at 14 Analyst Recommendations For Johnson & Johnson
Portfolio Pulse from Benzinga Insights
In the last three months, 14 analysts have published ratings on Johnson & Johnson (NYSE:JNJ), with a mix of bullish and bearish perspectives. The average 12-month price target is $183.5, slightly down from the previous $185.14. Key analysts have maintained or adjusted their ratings and price targets, reflecting their views on the company's performance. Johnson & Johnson has shown solid financial performance with a 4.31% revenue growth rate, a 20.88% net margin, and a prudent debt management strategy.
July 30, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Johnson & Johnson has received mixed analyst ratings over the past three months, with a slight decrease in the average 12-month price target. The company's solid financial performance, including a 4.31% revenue growth rate and a 20.88% net margin, supports a stable outlook.
The mixed analyst ratings and slight decrease in the average price target suggest a neutral short-term impact on JNJ's stock price. However, the company's strong financial performance provides a stable outlook, balancing the overall sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100